Shareholder alert: ademi llp investigates whether provention bio, inc. has obtained a fair price in its transaction with sanofi

Milwaukee , march 13, 2023 /prnewswire/ -- ademi llp is investigating provention bio (nasdaq: prvb) for possible breaches of fiduciary duty and other violations of law in its transaction with sanofi.  click here to learn how to join the action https://www.ademilaw.com/case/provention-bio-inc or call guri ademi toll-free at 866-264-3995.
PRVB Ratings Summary
PRVB Quant Ranking